World's Best Scientists 2026 revealed!
Curtis A. Hanson

Curtis A. Hanson

D-Index & Metrics

Medicine

D-Index
99
Citations
33841
World Ranking
8635
National Ranking
4454

Overview

Curtis A. Hanson is affiliated with the Mayo Clinic in the United States and has an extensive publication record in the field of medicine, with a focus on genetics, hematology, pathology and forensic medicine, molecular biology, and immunology.

Their research primarily addresses the topics of chronic lymphocytic leukemia research, lymphoma diagnosis and treatment, myeloproliferative neoplasms diagnosis and treatment, immunodeficiency and autoimmune disorders, chronic myeloid leukemia treatments, acute myeloid leukemia research, and Kruppel-like factors research.

Among their recent papers are:

  • Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera, 2020, British Journal of Haematology
  • Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial, 2022, Blood
  • Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases, 2021, American Journal of Hematology
  • The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL, 2021, Blood
  • Mutations and thrombosis in essential thrombocythemia, 2021, Blood Cancer Journal

Frequent co-authors in their collaborations include Neil E. Kay, Kari G. Rabe, Sameer A. Parikh, Susan L. Slager, and Esteban Braggio.

Their work has been published repeatedly in key venues in hematology and related fields, including:

  • Blood (26 publications)
  • Blood Cancer Journal (11 publications)
  • American Journal of Hematology (9 publications)
  • Clinical Lymphoma Myeloma & Leukemia (6 publications)
  • Leukemia (5 publications)

Best Publications

  • DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

    Naseema Gangat;Domenica Caramazza;Rakhee Vaidya;Geeta George

  • Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

    Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

    Tait D. Shanafelt;Xin V. Wang;Neil E. Kay;Curtis A. Hanson

  • TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

    A. Tefferi;A. Pardanani;K. H. Lim;K. H. Lim;O. Abdel-Wahab

  • Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

    Tiziano Barbui;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Mythri Mudireddy

  • Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.

    G. Barosi;R. A. Mesa;J. Thiele;F. Cervantes

  • Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

    A Pardanani;T L Lasho;C Finke;C A Hanson

  • The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Joannah Score

  • Targeted deep sequencing in polycythemia vera and essential thrombocythemia

    Ayalew Tefferi;Terra L. Lasho;Paola Guglielmelli;Christy M. Finke

  • Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival

    A Tefferi;T L Lasho;J Huang;C Finke

  • CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

    A Tefferi;P Guglielmelli;T L Lasho;G Rotunno

  • A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.

    Ayalew Tefferi;Terra L. Lasho;Kebede H. Begna;Mrinal M. Patnaik

  • Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia

    Ruben Mesa;C. A. Hanson;S. V. Rajkumar;G. Schroeder

  • Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia

    Gordon W. Dewald;Stephanie R. Brockman;Sarah F. Paternoster;Nancy D. Bone

  • Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

    Tefferi A;Lim Kh;Lim Kh;Lim Kh;Abdel-Wahab O;Lasho Tl

  • A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.

    Francesco Passamonti;Jürgen Thiele;Francois Girodon;Elisa Rumi

  • Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.

    Diane F. Jelinek;Renee C. Tschumper;Susan M. Geyer;Nancy D. Bone

  • ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.

    M M Patnaik;R Itzykson;T L Lasho;O Kosmider

Frequent Co-Authors

Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Terra L. Lasho
Terra L. Lasho Mayo Clinic
Neil E. Kay
Neil E. Kay Mayo Clinic
Tait D. Shanafelt
Tait D. Shanafelt Stanford University
Susan L. Slager
Susan L. Slager Mayo Clinic
Kari G. Rabe
Kari G. Rabe Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in a medical career or expanding their healthcare expertise, many alternative online pathways offer flexibility and affordability. If you're considering entry-level positions in the healthcare sector, billing and coding classes online provide a solid foundation for working with medical records and insurance systems. These programs are ideal for those who want to quickly gain employable skills with minimal upfront investment.

Aspiring nurses or those wishing to advance their nursing careers can choose from affordable online nursing programs that cater to various experience levels. For nurses aiming for expanded clinical roles and higher salaries, consider exploring affordable np programs. These allow Registered Nurses to specialize as Nurse Practitioners while maintaining work-life balance through online study.

For those passionate about research, academia, or leadership in nursing, pursuing online phd programs in nursing can open doors to top-tier career opportunities. With a range of affordable and flexible degree options available, the path to a rewarding medical or healthcare-related career has never been more accessible.

Best Scientists Citing Curtis A. Hanson

Trending Scientists

Recently Published Articles